基因测试公司Tempus AI（TEM）今日盘中大涨7.49%，引发市场广泛关注。截至发稿时，该股报价54.83美元。
根据公司最新发布的财报，Tempus AI第一季度营收同比增长75%，达到2.557亿美元，高于华尔街分析师预期的2.481亿美元。季度调整后每股亏损为24美分，优于预期的27美分。更值得注意的是，公司将2025年全年营收预期从此前的12.4亿美元小幅上调至12.5亿美元，高于市场一致预期的12.2亿美元。
Tempus AI公司创始人兼首席执行官埃里克·莱夫科夫斯基（Eric Lefkofsky）表示："我们在人工智能领域的战略投资使我们在推动诊断和药物开发领域的发展方面具有独特优势。"近期，Tempus AI与阿斯利康和Pathos AI公司达成合作，共同建立肿瘤领域最大的基础模型，这一消息曾使公司股价在4月23日大涨约15%。随着今日的上涨，Tempus AI的股价今年以来已上涨约63%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.